Forian (NASDAQ:FORA) Shares Down 2% – What’s Next?

Forian Inc. (NASDAQ:FORA) dropped 2% during mid-day trading on Monday . The company traded as low as $1.99 and last traded at $2.00. Approximately 10,769 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 16,409 shares. The stock had previously closed at $2.04.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reissued a “buy” rating and set a $5.00 price objective on shares of Forian in a report on Thursday, November 14th.

Forian Price Performance

The firm has a market capitalization of $62.03 million, a price-to-earnings ratio of -22.22 and a beta of 1.07. The business has a fifty day moving average price of $2.07 and a two-hundred day moving average price of $2.33.

Hedge Funds Weigh In On Forian

A hedge fund recently raised its stake in Forian stock. Canton Hathaway LLC grew its holdings in Forian Inc. (NASDAQ:FORA) by 2.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 269,650 shares of the company’s stock after acquiring an additional 6,125 shares during the period. Canton Hathaway LLC owned about 0.87% of Forian worth $582,000 at the end of the most recent quarter. Institutional investors and hedge funds own 19.25% of the company’s stock.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.